SCHEMBL3540736

SCHEMBL3540736

CC1CCN(c2nc(N3CCN(C(=O)CN4CCOCC4)CC3)ccc2N)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.55
KDM4E B2RXH2 4/20 0.55
RECQL P46063 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.46
KMT2A Q03164 3/20 0.46
TDP1 Q9NUW8 1/20 0.46
TSHR P16473 2/20 0.46
HSD17B10 Q99714 3/20 0.44
ALOX15 P16050 1/20 0.44
SMO Q99835 1/20 0.44
TLR8 Q9NR97 1/20 0.41
TLR7 Q9NYK1 1/20 0.41
RAB9A P51151 2/20 0.40
MAPK1 P28482 1/20 0.40
LMNA P02545 1/20 0.40
MEN1 O00255 3/20 0.39
NAMPT P43490 1/20 0.39
HTT P42858 1/20 0.39
NPC1 O15118 1/20 0.39
CSF1R P07333 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3534730 0.96 ALDH1A1 (0.50) ALDH1A1KDM4ERECQLSMN1; SMN2KMT2A
Trifluoroacetic Acid SCHEMBL3542661 0.94 ALDH1A1 (0.49) ALDH1A1KDM4ERECQLSMN1; SMN2KMT2A
SCHEMBL3539286 0.85 TDP1 (0.53) ALDH1A1KDM4ERECQLSMN1; SMN2KMT2A
SCHEMBL13767720 0.82 CSF1R (0.56) ALDH1A1KDM4ERECQLSMN1; SMN2KMT2A
SCHEMBL5188971 0.81 ALDH1A1 (0.55) ALDH1A1KDM4ERECQLSMN1; SMN2KMT2A
SCHEMBL3537014 0.81 MAPT (0.48) ALDH1A1KDM4ERECQLKMT2ATDP1
SCHEMBL13405756 0.77 CSF1R (0.72) ALDH1A1KDM4ERECQLCSF1R
SCHEMBL3535973 0.74 HTR3A (0.49) ALDH1A1KDM4EKMT2ATSHRMEN1
SCHEMBL13405754 0.74 CSF1R (0.72) ALDH1A1KDM4ERECQLCSF1R
SCHEMBL3965424 0.74 ALDH1A1 (0.46) ALDH1A1KDM4ERECQLSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807407-B1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2009-07-29 EP claimed
US-7705042-B2 Class of arylamide compounds useful as inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2010-04-27 US disclosed
US-7705042-B2 Class of arylamide compounds useful as inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2010-04-27 US disclosed
US-7705042-B2 Class of arylamide compounds useful as inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2010-04-27 US disclosed
EP-1807407-B1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2009-07-29 EP disclosed
EP-1807407-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-18 EP disclosed
US-20060100201-A1 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-11 US disclosed
WO-2006047504-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100201-A1 Inhibitors of c-fms kinase MUSK, FLT3, FES ALDH1A1 4796/4885KDM4E 2242/4885RECQL 3672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.